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ABSTRACT
Primary and secondary structures of mammalian
mitochondrial (mt) tRNAs are divergent from
canonical tRNA structures due to highly skewed
nucleotide content and large size variability of D-
and T-loops. The nonconservation of nucleotides
involved in the expected network of tertiary
interactions calls into question the rules governing
a functional L-shaped three-dimensional (3D) struc-
ture. Here, we report the solution structure of
human mt-tRNA
Asp in its native post-transcrip-
tionally modified form and as an in vitro transcript.
Probing performed with nuclease S1, ribonuclease
V1, dimethylsulfate, diethylpyrocarbonate and lead,
revealed several secondary structures for the
in vitro transcribed mt-tRNA
Asp including predomi-
nantly the cloverleaf. On the contrary, the native
tRNA
Asp folds into a single cloverleaf structure,
highlighting the contribution of the four newly
identified post-transcriptional modifications to
correct folding. Reactivities of nucleotides and
phosphodiester bonds in the native tRNA favor exis-
tence of a full set of six classical tertiary interactions
between the D-domain and the variable region,
forming the core of the 3D structure. Reactivities
of D- and T-loop nucleotides support an absence
of interactions between these domains. According
to multiple sequence alignments and search for
conservation of Leontis–Westhof interactions, the
tertiary network core building rules apply to all
tRNA
Asp from mammalian mitochondria.
INTRODUCTION
Transfer RNAs (tRNAs) constitute key molecules in
protein biosynthesis in all living organisms. To fulﬁll
their biological role, they have speciﬁc structural
properties allowing interactions with several partners
such as their cognate aminoacyl-tRNA synthetases
(aaRSs), elongation factor, mRNA or ribosome (1).
Presently, several thousands of tRNA sequences are
known (2). A vast majority of them fold into the canonical
cloverleaf secondary structure, and furthermore into a
three-dimensional (3D) functional L-shape as ﬁrst
revealed by the crystal structure of tRNA
Phe (3,4).
Transition from 2D to 3D structure is supported by nine
tertiary interactions involving conserved and semi-
conserved residues that are localized within the D- and
the T-loops, and within the core of the molecule (connec-
tor regions, D-stem and variable region). The tertiary
interaction network is conserved in bacterial, archaeal
and eukaryal cytosolic tRNAs. It involves nucleotides
which either form atypical base-pairs or triple
interactions, the latter made either of three remote
nucleotides or of a Watson–Crick pair and an additional
distant nucleotide (5,6).
A major unanswered question, however, concerns the
3D folding rules for mammalian mitochondrial tRNAs
(mt-tRNAs) for which sequences are not canonical.
Sequence comparison of these tRNAs, in addition to the
description of typical characteristics of secondary struc-
tures, highlighted ‘bizarre’ features (7). Exceptionally
of tRNA
Ser(AGY) is missing the full D-domain and
tRNA
Ser(UCN) has an extended anticodon stem.
Mammalian mt-tRNAs present other unprecedented size
variations in both D- and T-loops and lack a number
of conserved and semi-conserved residues essential to
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Asn) show strong con-
servation of the nine potential classical tertiary inter-
actions, including those between the D- and T-loops,
and may thus well fold into the canonical L-fold (7).
For all other families, a gradual disappearance of the the-
oretical tertiary interactions is observed; in extreme
examples only three of them can be predicted (7). A few
mammalian mt-tRNAs have been investigated experimen-
tally for their 3D structural features. Two atypical
tRNA
Ser(UCN) (8,9) and tRNA
Ser(AGY) (10) have been
studied by enzymatic and chemical structure probing
in solution, and a nuclear magnetic resonance (NMR)
structure was established for tRNA
Ser(AGY) (missing
the D-domain) (10). Transient electric birefringence
experiments showed that the angle between the two
branches of the ‘L’ is more obtuse for these two tRNAs
and for human mt-tRNA
Lys than for classical tRNAs
(120 –140  as compared to 70 –90  respectively) (11,12).
In the single case of bovine mt-tRNA
Phe, solution
mapping experiments with enzymatic and chemical
probes lead to 3D structural information on a moderately
diverging ‘bizarre’ mt-tRNA (13). In this tRNA, the
presence of the six expected tertiary interactions within
the core of the tRNA is supported experimentally and
the absence of conserved nucleotides G18G19 and
T54CG57 in the D- and T-loops, respectively, leads to
the absence of interaction between the corresponding
domains at the corner of the expected ‘L’ fold.
For a reﬁned understanding of the rules that govern the
folding of mammalian mt-tRNAs, we have tackled the
case of human mt-tRNA
Asp by structural mapping in
solution with enzymatic and chemical probes. This
tRNA has already been investigated to determine the
identity signals responsible for speciﬁc aspartylation by
human mt-AspRS (14). The number of such signals is
severely reduced in comparison with tRNA
Asp from
other kingdoms: only two important elements in the
anticodon triplet are maintained and the discriminator
nucleotide G73 is lost, suggesting a strongly degenerated
set of identity elements in mammalian mt aspartylation
systems (14). This observation prompted us to search for
concomitant structural alteration of the tRNA, in order to
gain some insight into structure/function evolution of
aminoacylation systems in mitochondria. Experiments
were performed on both native tRNA extracted from
HeLa cells and human placenta, containing all the post-
transcriptional modiﬁcations, as well as on the corre-
sponding in vitro transcript.
Here, the set of post-transcriptional modiﬁcations of
native human mt-tRNA
Asp has been deﬁned and a clover-
leaf retrieved as secondary structure. However, a combi-
nation of three alternate secondary structures, including a
cloverleaf, a cloverleaf with a large loop and an extended
bulged hairpin, has been discovered for the in vitro
transcribed RNA, demonstrating the high contribution
of post-transcriptional modiﬁcations to structure the
mt-tRNAs. Reactivities in native tRNA toward structural
probes are in favor (i) of the existence of an extensive
tertiary network of interactions forming the core of an
L-shaped structure and (ii) of the absence of interactions
between the D- and T-loops. The relevance of the rules
governing the tertiary network of human mt-tRNA
Asp
applied to other mammalian mt-tRNAs is discussed in
terms of conservation of Leontis–Westhof interaction
patterns in the six core tertiary interactions.
MATERIALS AND METHODS
Materials
Diethylpyrocarbonate (DEPC), aniline, hydrazine, TRI
REAGANT,5 0-biotinylated oligonucleotide and
streptavidin-coated beads were purchased from Sigma-
Aldrich. Nuclease T1 used for enzymatic structure
probing was from Stratagene, nuclease S1 as well as
ribonuclease V1 were from PIERCE. Dimethylsulfate
(DMS) was bought from Acros Organics. RNase T1
used for mass spectrometric analyses was purchased
from EPICENTRE Biotechnologies. Acrylonitrile was
purchased from Wako Pure Chemical Industries.
[g-
32P]ATP (3000Ci/mmol) was from Amersham.
Mass spectrometric analysis of the post-transcriptional
modiﬁcations in human mt-tRNA
Asp
Mt-tRNA
Asp puriﬁed from human placenta as described
previously (15,16) was provided by Dr. Yohei Kirino
(Univ. of Pennsylvania). The sequence of a synthetic
30-biotinylated DNA for the chaplet column chromatog-
raphy was 50-taagatatataggatttagcctataattta-30. The
puriﬁed tRNA
Asp (250fmol) was digested by RNase T1
or RNase A, and then analyzed by capillary liquid chro-
matography (LC)/nano electrospray ionization mass
spectrometry (nanoESI-MS) as described (17). A linear
ion trap-orbitrap hybrid mass spectrometer (LTQ
Orbitrap XL, Thermo Fisher Scientiﬁc) was equipped
with a custom-made nanospray ion source and a splitless
nano HPLC system (DiNa, KYA Technologies).
Cyanoethylation was carried out according to the litera-
ture (18) with slight modiﬁcations. Reaction mixture
(16ml) consisting of 1mlo f1 mM tRNA
Asp,1 3 mlo f
1.1M triethylammonium acetate (pH 7.0) with 41%
ethanol and 2ml of acrylonitrile was incubated at 70 C
for 2hours. After cyanoethylation, the mixture was
lyophilized and dissolved with water. Half the amount
was digested by RNase T1, then subjected to the
LC/nanoESI-MS analysis.
Structural mapping in solution
Native tRNA was prepared from HeLa cell mitochondria
according to established procedures. Total mitochondrial
tRNAs were extracted by using the TRI REAGANT
method following the manufacturer’s procedure. Speciﬁc
mitochondrial tRNA
Asp was isolated from total tRNAs as
previously described in (19,20) by hybridization to a
50-biotinylated oligonucleotide bound to streptavidin
coated beads and complementary to 34nt at the 50-end
of the tRNA. The gene for human mt-tRNA
Asp has
been cloned previously (21) including a hammerhead
ribozyme (22) and tRNA sequence downstream of the
6882 Nucleic Acids Research, 2009,Vol.37, No. 20T7 polymerase promoter. A BstNI site was inserted coin-
cidental with the 30-end of the tRNA sequence, which
allows the synthesis of tRNA ending with the expected
CCA sequence. In vitro transcription was performed as
described in (21) with adequate amounts of T7 RNA
polymerase (puriﬁed according to ref. 23). After phenol
extraction, the transcript was puriﬁed on denaturing
12% polyacrylamide/8M urea gels, electroeluted and
ethanol-precipitated.
Structural mapping of tRNAs was done using enzy-
matic (nuclease S1, speciﬁc for single-stranded region
and ribonuclease V1, speciﬁc for duplex or highly
structured region) and chemical (DMS, speciﬁc for N3
of cytosine, DEPC, speciﬁc for N7 of adenosine, and
lead (Pb
2+), speciﬁc for single-stranded regions) probes.
[
32P]-labeling of the tRNA transcript 50-end and the sub-
sequent puriﬁcation of tRNA molecules from
polyacrylamide gels were carried out as described earlier
(24). Before structural probing, transcripts were denatured
by heating at 60 Ci nH 2O and slowly cooled down to
room temperature.
Enzymatic probing. Digestion with nuclease S1 or
ribonuclease V1 were performed as described (24).
Brieﬂy, transcripts were incubated in 50mM HEPES-
KOH pH 7.5, 10mM MgCl2 and 25mM KCl for 5min
at 25 C. For digestion with S1 nuclease, 1mM ZnCl2
was added. Reaction mixtures (10ml) contained 30000
Cerenkov c.p.m. of transcript supplemented with 2mgo f
unlabeled Escherichia coli total tRNA and either 12.8U
nuclease S1 or 3.6.10
–2U RNase V1. Cleavage reactions
were performed during 5min at 25 C and were stopped by
adding 1vol of 0.6M AcONa pH 5, 3mM EDTA and
0.1mg/ml E. coli total tRNA followed by ethanol
precipitation.
Chemical probing. Modiﬁcation of N7 atoms of guanosine
residues and of N3 atoms of cytosine residues by DMS,
and modiﬁcation of N7 positions of adenosine by DEPC
were done according to established procedures (25).
Optimal concentration of chemicals and incubation
times for mt-tRNA transcripts were chosen as described
(24). Under native conditions, DMS reactions were for
10min at 25 C in 50mM HEPES-NaOH pH 7.5, 5mM
Mg(OAc)2, 50mM K(OAc) and 2mM b-mercap-
toethanol. Semi-denaturing conditions were for 5min at
25 C in 50mM HEPES-NaOH pH 7.5, 50mM K(OAc),
1mM EDTA and 2mM b-mercaptoethanol. Denaturing
conditions were for 30s at 60 C in 50mM HEPES-NaOH
pH 7.5 and 1mM EDTA. DEPC modiﬁcation was as with
DMS but incubation times were 10 and 20min for native
and semi-denaturing conditions and 5s for the denaturing
one. Cleavage reactions were performed for 10min in the
dark at 60 C using 10ml of a modiﬁed aniline solution
(100ml 1M aniline, 60mlC H 3COOH and 930mlH 2O).
Concerning the DMS, the cleavage reaction was
preceded by a second modiﬁcation using 10ml hydrazine
50% (v/v in water) for 5min in the dark. Between all the
modiﬁcation and the cleavage steps, tRNAs were ethanol
precipitated. All cleavage products were analyzed on
denaturing polyacrylamide gels as described below.
Cleavage by Pb(OAc)2 was performed as described in
(26). Brieﬂy, transcripts were incubated in 50mM HEPES-
NaOH pH 7.5, 5mM Mg(OAc)2 and 50mM K(OAc) for
10min at 25 C. A freshly prepared Pb(OAc)2 solution in
water was added to ﬁnal concentrations of 5 and 25mM.
Samples (10ml) were incubated at 25 C for 5min.
Reactions were stopped by cooling on ice, adding
EDTA to a ﬁnal concentration of 33mM and ethanol
precipitated. Control without probe was run in parallel.
Assignment of cleavage positions. Alkaline ladders were
performed by incubation of labeled transcripts (30000
Cerenkov c.p.m.) and 2mg of total tRNA from E. coli in
50mM NaHCO3 pH 9, at 80 C for 8min. Guanine
ladders were obtained by incubation of labeled transcripts
in 10mM Na-citrate pH 4.5, 3.2M urea, 0.4mM EDTA
and 2mg of unlabeled E. coli total tRNA for 4min at 60 C
followed by the addition of 2U RNase T1 and a second
incubation at 60 C for 4min. The products of the probing
reactions were analyzed on 12% polyacrylamide/8M urea
denaturing gels. Controls without probes but supple-
mented with ZnCl2 were run in parallel on each gel.
Mt-tRNA
Asp 3D modeling
A 3D model of human mt-tRNA
Asp was built on the basis
of the crystallographic structure of E. coli tRNA
Asp in
complex with AspRS (PDB id: 1C0A) (27). Sequence
changes as well as base and phospho-ribose backbone
manipulations were performed with ‘O’ (28) and
‘assemble’ (http://www.bioinformatics.org/assemble/ -ref.
29), and conjugate-gradient minimization (500 cycles
in restrained Cartesian mode) of the model (including
hydrogen atoms) was performed with CNS (30). Figures
of the 3D model were prepared with PyMol (31).
RESULTS
Background
Figure 1A recalls nucleotides involved in the network
of tertiary interactions sustaining classical tRNA 3D
structures (tRNAs from bacteria, archae, eukaryotic
cystosol; ref. 5,6). Nine interactions are present. Most of
the network takes place in the core of the molecule,
namely in the D-arm and the variable region, involving
nucleotides which either form a pair at long-distance (i.e.
R15-Y48, N26-N44 with R for purine, Y for pyrimidine,
N for any nucleotide), or which form triples. Triples
involve either a base pair formed along the secondary
structure and a single nucleotide at distance (i.e. 9/12-23,
13-22/46, 45/10-25), or 3nt unrelated in the secondary
structure (i.e. U8-A14-A21). Three further interactions
involve the T- and D-loops, one interaction within the
T-loop (T54-A58) and two interactions bringing the two
loops close to each other (G18-55, G19-C56), to form
the elbow of the ‘L’. Mammalian mt-tRNA
Asp (Figure 1B)
deviate from canonical tRNAs by sizes of D- and T-loops
and by the lack of several conserved and semi-conserved
residues essential to the establishment of the tertiary
interaction network. Strategic nucleotides, especially
nucleotides G18 and G19 in the D-loop, and nucleotides
Nucleic Acids Research, 2009,Vol.37, No. 20 6883U54U55C56 of the T-loop are absent, leaving the question
open of the existence of any interaction between these
loops. By analogy to classical tRNAs, only four potential
tertiary interactions in the core of the 3D structure would
be conserved when the full set of available mammalian
mitochondria sequences of tRNA
Asp are considered
(7,32) (Figure 1B). Among them, the existence of the
triple interaction A9/A12-U23 has recently been experi-
mentally conﬁrmed while investigating the eﬀects of
myopathy-related mutation A7526G (A9G) on structure
and aminoacylation properties of mt-tRNA
Asp (33).
Post-transcriptional modiﬁcations in human mt-tRNA
Asp
Native mt-tRNA
Asp (Figure 2A) was isolated from human
placenta by the chaplet column chromatography (15,16).
To determine species and positions of the post-
transcriptional modiﬁcations, human mt-tRNA
Asp was
digested by RNase T1 or RNase A into fragments, and
analyzed by a highly accurate and sensitive method of
RNA mass spectrometry (capillary LC/nanoESI-MS)
(17). As shown in Figure 2B and Table 1, we could
detect negatively-charged ions of 15 digestion fragments
Figure 1. Tertiary interaction networks in tRNAs. (A) Canonical tRNA (e.g. bacterial, archaeal, eukaryotic cytosolic). Data are according to
crystallographic structures (5,6). Nucleotide positions involved in the nine tertiary interactions are indicated in bold. They are either strictly
conserved, semi-conserved (Y for pyrimidine, R for purine) or not conserved (black dots) and bring together secondary structural domains (top)
into an L-shaped 3D fold (bottom). Other strictly conserved or semi-conserved nucleotides are indicated in gray. Numbering is according to (2).
Residues 8, 9 and 26 are considered as connectors between domains. (B) Mammalian mitochondrial tRNA
Asp. The displayed ‘typical’ secondary and
tertiary interactions have been compiled under ‘Mamit-tRNA’ data (http://mamit-trna.u-strasbg.fr/, 32) by alignment of 136 sequences. Nucleotides
in black and bold characters are strictly conserved. Those indicated in black are conserved to  90%. Dominance of a given nucleotide in  50% and
 90% of sequences as well as semi-conservation (Y or R) is indicated in grey. Conservation  50%, is represented by open circles. Due to large size
and sequence variations in D- and T-loops, no sequence conservation can be indicated. Four tertiary interactions can be predicted in the core of the
molecule. No interaction between the D- and T-loops can be anticipated in any mitochondrial tRNA
Asp sequence.
6884 Nucleic Acids Research, 2009,Vol.37, No. 20produced by RNase T1 and RNase A digestions that
cover the whole sequence of mt-tRNA
Asp. According to
the observed values of singly or multiply charged ions, the
exact molecular masses of the RNA fragments with or
without modiﬁcations could be unambiguously deter-
mined (Table 1). Each fragment was further analyzed
by a MS/MS experiment using collision-induced dissocia-
tion (CID) to position the detected modiﬁcations in
the tRNA sequence. The MS/MS analysis of fragment
No. 4 (Table 1) determined 1-methyladenosine (m
1A) at
position 9 and N
2-methylguanosine (m
2G) at position
10 (Figure 2C). These two modiﬁcations are conserved
at the corresponding positions in several animal
mt-tRNAs (tRNAdb, (2), http://trnadb.bioinf.uni-leipzig
.de/). We also found m
2G at position 10 occurred partially
as observed in the CID spectrum of fragment No. 40
(UAUUm
1AGp) (Figure 2C). Judging from the peak
area in the mass chromatogram, about 50 % of G10 is
modiﬁed to m
2G10 (Figure 2B). The anticodon-containing
fragment (No. 1) showed a molecular mass of 27-mer
RNA containing a wobble modiﬁcation of queuosine
(Q). As it is known that Q is a modiﬁed G that is resistant
to RNase T1 digestion (34), Q can be assigned at position
34 in principle. We also observed partial modiﬁcation of
Q34 ( 10%), resulting in the detection of the 21-mer
RNA (No. 10) which was cleaved at position 34 by
RNase T1 (Figure 2B and Table 1). For detecting mass-
silent pseudouridine (),  in tRNA
Asp was cyanoethy-
lated by acrylonitril treatment, prior to RNase T1
digestion. We found the fragment No 10 increased in
molecular mass by 53Da, indicating a single  to be
present in this fragment. In the CID spectrum of the
cyanoethylated RNA fragments No. 10 (Figure 2D), the
quadruply charged product ion w80 (m/z 669.8212) exactly
matched with the m/z value containing cyanoethylated-.
On the contrary, in the CID spectrum of nonderivatized
No. 10 (Figure 2D), we detected the related product ion w8
(m/z 656.5684) which corresponds to the unmodiﬁed RNA
fragment. Besides, other product ions of 30-termini
including y1, y3, w4 and w5 are commonly found in
both CID spectra. These data demonstrate that W was




2G10 and Q34 as its post-transcriptional
modiﬁcations (Figure 2A).
Enzymatic and chemical solution structure of
native human mitochondrial tRNA
Asp
Structure probing in solution is based upon the reactivity
of RNA molecules toward chemicals or enzymes that have
a speciﬁc target on RNA (35–37). Probes are used under
statistical conditions where less than one cleavage or mod-
iﬁcation occurs per molecule. In the present work, acces-
sibility of the human mt-tRNA
Asp has been probed under
native conditions by nucleases speciﬁc for single-stranded
(nuclease S1) and double-stranded or structured regions
(ribonuclease V1). While the use of these enzymatic probes
allows deciphering of the overall secondary structure of
the RNA, a more precise investigation at the atomic
level involves the chemical probes DMS, DEPC and
Pb
2+. DEPC modiﬁcation at N7 position of adenine
residues and DMS modiﬁcation at N3 position of
cytosine residues can be detected by strand scission with
aniline. If these atoms are accessible and reactive in the
RNA 3D structure, they are detected under native
conditions. If they are involved in secondary or tertiary
structural elements, they are non-reactive under native
conditions but become detectable under semi-denaturing
and fully denaturing conditions.
Probing experiments have been performed at 25 C
on 50-o r3 0-end labeled tRNA molecules. Cleavage
fragments were revealed on denaturating 12% polyacry-
lamide gels. Representative autoradiograms of enzymatic
cleavage of native tRNA
Asp (with post-transcriptional
modiﬁcations) are presented in Figure 3A. Complete
data resulting from extensive probing with both enzymatic
and chemical probes are summarized on a cloverleaf
structure (Figure 3B). Control incubations without
probes conﬁrmed the intrinsic weakness of human
mt-tRNAs at pyrimidine-A bonds as already described
for tRNA
Lys (24) and tRNA
Leu(UUR) (38). All degra-
dations are annotated on the autoradiograms as well as
on the cloverleaf structure. For technical reasons, residues
1–10 and 74–76 could not be investigated.
Analysis of nucleotide reactivities to chemical probes
and of phosphodiester bonds to enzymatic probes within
native tRNA
Asp unambiguously reveals a classical clover-
leaf. Typical reactivities correspond to strong cleavages
by single-strand speciﬁc nuclease S1 all along residues
14–20 (corresponding to the D-loop), residues 32–35
(anticodon loop), residues 44 and 45 (variable region)
and residues 55 and 56 (T-loop), as well as cleavages by
the double-strand speciﬁc ribonuclease V1 all along
nucleotides 28, 29 (anticodon stem), 43 (end of anticodon
stem/entry of variable region), nucleotides 62–65 (T-arm)
and nucleotides 69, 70 and 72 (acceptor arm). Signiﬁcant
alkylation by DMS under native conditions, as revealed
by direct strand scission, is observed at the N3 position
of residues C16 and C20 (D-loop), C36 (anticodon loop)
and C54 (T-loop), whereas residues C26 (D-arm),
C30 (anticodon arm) and C61 and C62 (T-arm) are not
reactive under native conditions (not shown). These
residues become fully reactive under denaturing
conditions. Reactivities of adenosines to DEPC under
native conditions are strong for residues A21 (D-loop),
A37 and A38 (anticodon loop) and A56 and A57
(T-loop), while residues A11–A13 (D-arm), A28 and
A29 (anticodon arm) and A49, A51 and A64 (T-arm)
are not reactive. However, some reactivities do not ﬁt.
The phosphodiester bond 50 to nucleotide C20 (D-loop)
is cut by ribonuclease V1.
Unfortunately, the corresponding cleavage product
co-migrates with the product of degradation between
residues C20 and A21, therefore no conclusion about the
involvement of residue C20 within a tertiary interaction
can be proposed. Moreover, residues A12 and A13
(D-arm) are reactive towards the single-strand speciﬁc
nuclease S1.
Nucleotides within D- and T-loops deserve particular
attention. In the D-loop, all phosphodiester bonds are
cleaved by single-strand speciﬁc enzymatic probe, two
major degradations occur, and atomic positions of bases
Nucleic Acids Research, 2009,Vol.37, No. 20 6885Figure 2. Post-transcriptional modiﬁcations in human mt-tRNA
Asp (A) Secondary structure of human mt-tRNA
Asp (53) with modiﬁcations deter-
mined in this study. Abbreviations are used as follows: m
1A, 1-methyladenosine; m
2G, N
2-methylguanosine; , pseudouridine; Q, queuosine.
50-terminus ‘p’ and 30-terminus ‘OH’ represent monophosphate and hydroxy group, respectively. (B) Base peak chromatograms (BPC) of RNA
fragment analyses of human mt-tRNA
Asp digested by RNase T1 (upper panel) and RNase A (lower panel). Each fragment is numbered in the
chromatograms as described in Table 1. (C) Collision induced dissociation (CID) spectra of UAUUm
1Am
2Gp (upper panel) and UAUUm
1AGp
(lower panel). Precursor ions were m/z 982.6 and 975.6, respectively. Product ions, whose nomenclatures are mentioned by (76), are indicated in each
spectrum and on the sequence of each fragment. The charge state of product ions is indicated in parentheses. (D) CID spectra of
AAAAACCAUUUCAWAACUUUGp with (upper panel) or without (lower panel) cyanoethylation. Precursor ions m/z 747.9 (with cyanoethylation,
upper panel) and m/z 742.2 (without cyanoethylation, lower panel) were used for CID, respectively. The product ion containing cyanoethylated
pseudouridine(s) is marked with a prime notation. The insets show expanded ranges for m/z 655–659 and 668–672, respectively including
monoisotopic w8(-4) and w80(-4) ions.
6886 Nucleic Acids Research, 2009,Vol.37, No. 20are reactive to chemical probes. Accordingly, the possibil-
ity of interaction of this loop with another domain of the
RNA is restrained. T-loop nucleotides are also very
reactive to both single-strand speciﬁc enzyme and to
chemical probes. Further, degradation at U55/A56 is
strong. Accordingly, the T-loop nucleotides are not
protected against structural probes by any neighboring
RNA domain. Nonreactivity of several atomic positions
to chemical probes can be interpreted by intrinsic folding
of either loop. N7 of A58 is likely to reﬂect a stacking with
neighboring nucleotides C54 and/or U55. The present
data are not in support of D- and T-loop interactions.
The absence of reactivity of N7 A14 ﬁts with an interac-
tion with residue U8 through a Hoogsteen interaction as
Figure 3. Solution structural mapping of human native mitochondrial tRNA
Asp, extracted from HeLa cells. (A) Autoradiograms of typical
polyacrylamide gels on which ribonuclease V1 and nuclease S1 enzymatic cleavage products were mapped. tRNA was either 50-end (left panel) or
30-end (right panel) labeled with [
32P]. C: control incubation in the absence of probes, L: alkaline degradation, T1: G-ladder under denaturing
conditions, V1 and S1: cleavage in presence of either structural probe under native conditions (see ‘Materials and Methods’ section). Numbering of
nucleotides and theoretical secondary domains are given on both sides of the panels. Chemically fragile phosphodiester bonds at Y-A stretches are
indicated in italics with the name of the 50Y nucleotide. (B) Reactivities to enzymatic and chemical (autoradiograms not shown) probes under native
conditions presented on the theoretical cloverleaf secondary structure of mt-tRNA
Asp. For detailed legend, see inset. For enzymatic probes, the size
of the arrows is proportional to cleavage intensity.
Table 1. List of RNA fragments from human mitochondrial tRNA
Asp detected by MS analysis
No Sequences of RNA fragments Molecular mass Monoisotopic m/z Charge state
Observed Calculated
RNase T1 fragments
1 AAAAACCAUUUCAWAACUUUQUCAAAGp 8756.213 795.0098 795.012  11
10 AAAAACCAUUUCAWAACUUUGp 6686.873 741.9777 741.978  9
2 CUAAAUCCUAUAUAUCUUACCA (30 terminus) 6848.915 683.9017 683.884  10
3 UUAAAUUAUAGp 3538.447 706.6801 706.682  5
4 UAUUm
1Am
2Gp 1967.270 982.6292 982.627  2
40 UAUUm
1Agp 1953.255 975.6188 975.619  2




2GAAAAACp 2670.446 1334.2153 1334.215  2
7 pAAGGUp (50 terminus) 1752.202 875.0916 875.093  2
8 AAAGUp 1656.241 827.1147 827.113  2
9 AGGCp 1342.199 670.0933 670.092  2
10 AAAUp 1311.193 654.5911 654.589  2
11 AACp 981.157 980.1503 980.149  1
12 AUp or AWp 653.088 652.0830 652.081  1
13 ACp 652.104 651.0989 651.097  1
Nucleic Acids Research, 2009,Vol.37, No. 20 6887in classical tRNAs (6). Reactivity of N7 A21 to DEPC
under native conditions is in agreement with interaction
of residues A14 and A21 in a way not involving the
Hoogsteen side.
The D-stem and variable region of mt-tRNA
Asp are rich
in adenosine residues. None of these adenosines
(A11–A14, and A44–A46) is reactive to DEPC under
native conditions. Accordingly, their N7 atoms are
involved in a higher-order structure. They can be protected
against DEPC either due to stacking with neighboring
bases and/or due to hydrogen bonding within tertiary
interactions. Nonreactivity of N7 A45 supports an
involvement in the triple interaction G10-C25/A45
and non-reactivity of N7 A46 with an involvement in
the triple A13-U22/A46. Nonreactivity of N7 of A26 and
A44 is in agreement with their involvement in stacking.
Enzymatic and chemical solution structure of in vitro
transcribed human mitochondrial tRNA
Asp
Probing experiments on in vitro transcribed mt-tRNA
Asp
have been performed using the same enzymatic and
chemical probes as for native tRNA, under similar
conditions. In addition, reactivity to Pb
2+ has been
investigated. Representative autoradiograms and the full
set of reactivities under native conditions are summarized
on the theoretical cloverleaf structure (Figure 4A1 and
A2). Control incubations without probes conﬁrmed
the intrinsic higher sensitivity of the transcript as
compared to native tRNA extracted from human cells,
at pyrimidine-A bonds (as already described in 24,38).
These degradations are annotated along the autora-
diograms as well as localized on the cloverleaf structure.
As was the case for the native tRNA, reactivities of
residues 1–9 and 74–76 could not be observed.
Comparing the cleavage pattern of this molecule to
native tRNA
Asp, the same reactivities of residues A28 to
C30, U32 to U41 and C61 to A73 towards enzymatic
(nuclease S1 and ribonuclease V1) and chemical probes
(DMS and DEPC) can be observed and are therefore com-
patible with a secondary cloverleaf structure. Reactivity of
the variable region nucleotides to chemical probing (N7 of
A44 and A45 are reactive to DEPC and A44 to U47 are
sensitive to the Pb
2+) is also consistent with this second-
ary structure. However, the other nucleotides display a
mixture of opposite reactivities. Thus, the D-arm can be
either be structured or open. A11 to A13 and U22 to U24
are cut by the double-strand speciﬁc ribonuclease V1 but
also by the single-strand speciﬁc nuclease S1 and are sen-
sitive to the lead probe. It should also be noticed that
residues G10 and C25 are also cleaved by the two latter
probes. Along the same trend, N7 atoms of residues
A11 to A13 are reactive to DEPC. Two incompatible
cleavage patterns within the theoretical D-loop are also
observed. While N7 of adenosine and N3 of cytosine are
reactive toward single-strand speciﬁc probes, nucleotides
A14–A21 are reactive to Pb
2+ and nucleotide A14 to
nuclease S1, ribonuclease V1 cuts can be observed for
all the nucleotides belonging to the loop (A14–A21).
Two residues of the anticodon arm (U42 and A43) are
reactive not only to RNase V1 (in agreement with the
presence of an arm) but also to Pb
2+. In addition, N7
of A43 is reactive to DEPC. Contradictions of these
types are also observed in the T-arm. On one the one
hand, nucleotides A49–A51 and C62–A64 are cleaved by
ribonuclease V1 and N7 atoms of residues A49 and A64 as
well as N3 atoms of residues C61 and C62 are not reactive
toward chemical probes. On the other hand, A49 and U50
are sensitive to nuclease S1 and N7 of A51 is reactive
to DEPC. Finally, reactivities of the N3 of C53 as well
as the N7 of A55 and A56 toward the chemical probes,
C53–A55 toward the Pb
2+ and A55 and A56 toward
the nuclease S1 are in agreement with the presence of a
T-loop. Reactivity of N7 position of residue A58 to DEPC
under semi-denaturing conditions and discrete cleavage
by ribonuclease V1 of A55 are in agreement with an
internal loop interaction (between A58 and C54).
Considering all these data, it can be concluded that
the in vitro transcribed mt-tRNA
Asp mainly folds into a
secondary cloverleaf structure but alternative structures
are also present. Figure 4B presents two possible alter-
native folds to the cloverleaf, namely a cloverleaf with
an open D-domain and an extended hairpin structure.
Database analysis
A set of 136 mammalian mt-tRNA
Asp sequences is avail-
able in the speciﬁc mammalian mt-tRNA database
Mamit-tRNA (32). Figure 1B shows the most typical com-
bination of nucleotides present in this group of molecules.
A large variability in D- and T-loop size is observed. A
more detailed analysis reveals three main types of D-loop
sequences (50-AAA-30;5 0-AAYYA-30;5 0-AAYAA-30)
(Y for pyrimidines) and three main types of T-loop
sequences (50-TGAAAAT-30;5 0-TYAAAYY-30;5 0-TTTA
AAT-30). Whatever the combination of the facing loops,
no obvious Watson–Crick interaction can be drawn.
Structural weaknesses of D-/T-loops interaction are not
likely to be compensated within the tRNA itself, in
contrast to various internal compensations observed in a
number of highly bizarre tRNAs from animal mito-
chondria (39–41).
Withregardtocoreinteractions,theexistenceoffourout
of the six tertiary interactions appears possible, with most
typical sequences A26–R44, G10–Y25/R45; A12–U23/A9;
A13–U22/Y46. Considering a more detailed analysis
of these core interactions within mt-tRNA
Asp families in
diﬀerent mammalian super-order/orders allows a ﬁne
tuned view (Supplementary Data). In all families, conser-
vation of nucleotides is highly signiﬁcant, although not
absolute. This is in support of a strong contribution
of tertiary interactions within the core to drive the folding
of mammalian mt-tRNA
Asp. To search in a ﬁner way
for conservation of tertiary interactions, the set of the
six candidate interactions in the core has been analyzed
according to the Leontis–Westhof rules of nucleotide
interactions (42). These rules propose a classiﬁcation
and nomenclature of nucleoside interactions found in
crystal structures, according to the ‘edges’ participating in
the interaction and to the orientation of the glycosidic
bonds relative to the hydrogen bonds. This format allows
identiﬁcation of pairs that co-vary or interchange in
6888 Nucleic Acids Research, 2009,Vol.37, No. 20sequence between homologous molecules while maintain-
ing the 3D topology. Table 2 summarizes the six core
interactionschemes(involving16nt)inthe136mammalian
mt-tRNA
Asp sequences and their comparison to inter-
action patterns found in classical tRNAs. As an outcome,
98.3% of interactions are strictly conserved, in strong
support for the existence of the full set of classical tertiary
interactions in the core of mammalian mt-tRNA
Asp. These
interactions in the core domain are depicted in the
Supplementary Data.
DISCUSSION
In vitro transcribed mt-tRNA
Asp folds into a variety
of secondary structures
Enzymatic and chemical probing of the in vitro
transcribed human mt-tRNA
Asp reﬂects the existence
of alternative structures. In addition to the dominant
classical cloverleaf, large nucleotide stretches cleaved
by nuclease S1 or by lead, and with reactivity to
chemical probes under native conditions suggest a
Figure 4. Solution structure probing of in vitro transcribed human mt-tRNA
Asp.( A) Experimental results. (A1) Autoradiograms of typical
polyacrylamide gels for enzymatic mapping with ribonuclease V1 and nuclease S1 (left), chemical probing with DEPC (center) and Pb(OAc)2
(right). tRNA was 50-end [
32P]-labeled and submitted to denaturation at 60 C and further renaturation before submission to probes under native
conditions (see ‘Materials and Methods’ section). C: control incubation in the absence of probes, L: alkaline degradation, T1: G-ladder under
denaturing conditions, V1 and S1: cleavage in presence of either structural probes, N and SD in the central panel correspond to decreasing amounts
of DEPC under native and semi-denaturing conditions, respectively, two concentration of Pb(OAc)2 have also been used. Numbering of nucleotides
and theoretical secondary domains are given along the panels. Chemically fragile phosphodiester bonds at Y-A stretches are indicated in italics with
the name of the 50Y nucleotide. (A2) Theoretical secondary structure cloverleaf with all observed reactivities to probes. For detailed legend, see inset.
For enzymatic probes, the size of the arrows is proportional to cleavage intensity. (B) In vitro transcribed human mt-tRNA
Asp exists under several
conformations. Reactivity to enzymatic and chemical probes are in strong support of the existence of alternative conformations. Their sorting
out reveals at least two alternative structures to the cloverleaf (left), namely a cloverleaf with an open D-stem (center) and an extended bulged
hairpin (right).
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Asp
6890 Nucleic Acids Research, 2009,Vol.37, No. 20version with an unstructured D-domain. A further fold
corresponds to an extended hairpin. In comparison to
the initial cloverleaf, this structure maintains the 7bp of
the acceptor stem and part of the anticodon domain.
On the contrary, the D- and T-domains are totally
refolded with numerous interdomain base pairs. The
existence of alternate structures of in vitro transcripts
has already been observed for other human mt-tRNAs
(43,44). This situation was ﬁrst characterized for
tRNA
Lys that does not adopt a cloverleaf but two alter-
native extended hairpins. In this case, the occurrence of
a cloverleaf requires the presence of modiﬁed nucleo-
tides (24,45). A single methyl group at position 9
(m
1A9) is of major importance in this process since it
hinders base pairing of nucleotide 9 with nucleotide 64
in the T-stem (this can also be achieved by mutating A9
to C, or U64 to A or C). All these variants show
cloverleaf-type probing patterns and are aminoacylated
by human lysyl-tRNA synthetase while the wild-type
transcript is not (45,46). Single-molecule FRET
analysis revealed that the wild-type in vitro transcribed
mt-tRNA
Lys exists in a conformational equilibrium
between cloverleaf and hairpin structures and that
methylation of residue A9 controls this equilibrium in
favor of an active cloverleaf (47,48). Enzymatic and
chemical probing experiments conducted on in vitro
transcribed tRNA
Ile (49) and tRNA
Leu(UUR) (38,50,51)
conﬁrmed the folding of these molecules into a second-
ary cloverleaf structure but further showed that they
could additionally adopt alternative structures such as
a cloverleaf with open D- and anticodon stems for the
tRNA
Leu(UUR) (38). The corresponding ‘ﬂoppy’ tertiary
structure of the anticodon arm in the expected L-shaped
tRNA
Leu(UUR) becomes converted into a functional
tRNA upon interaction with the cognate aminoacyl-
tRNA synthetase (52). In vitro transcribed tRNA
Tyr
however, preferentially folds into the cloverleaf (26).
This is in-line with the ranking of human mt-tRNAs
into two families according to the DNA-strand on
which they are encoded, both strands being highly
skewed in nucleotide composition (53). tRNA
Tyr is a
G-rich, ‘heavy’, human mt-tRNA and consequently
folds into a more stable structure than the highly A-,





present data on human mt-tRNA
Asp solution structures
are a new example demonstrating the intrinsic structural
plasticity of ‘light’ mt-tRNAs (primary sequence of this
tRNA includes 29A, 24U, 11C and 7G residues).
Post-transcriptional modiﬁcations restrict the 2D folding
space to a single cloverleaf
Human mt-tRNA
Asp presents four post-transcriptional
modiﬁcations, namely m
1A9, m
2G10, 27 and Q34.
Some of these modiﬁcations are only present partially,
i.e. all copies of the tRNA are not modiﬁed at all
positions, suggesting the existence of several
‘modivariants’ (54), as already observed for other human
mt-tRNAs (20). m
1A9 is typical for mt-tRNAs and is
very rare in other tRNAs (2,55). As discussed above, an
unprecedented structural role for this modiﬁcation was
revealed along studies of human mt-tRNA
Lys where the
methyl group hinders Watson–Crick base-pairing of
residue 9 with residue 64 (in the T-stem) and thus
hinders folding of the RNA into an extended hairpin
(24,45). m
1A9 was also shown to be crucial for structure
and function of nematode mt-tRNAs lacking the entire
T-arm (56). If this methyl group is inserted by the newly
discovered methylase activity of human mt-RNase P (57)
remains an open question. m
2G10 is a frequent modiﬁca-
tion in many tRNA families, which does not hinder
Watson–Crick interaction (2,55). 27 is present in about
20% of all tRNAs and stabilizes the base-pairing with A43
(58) and is present in many mt-tRNAs (2,55). The contri-
bution of 27 to mt-tRNA stability has been explicitly
demonstrated for bovine mt-tRNA
Met (59). Interestingly
also, the absence of 27 and 28 in human cytosolic and
mt-tRNAs has been correlated to sideroblastic anemiae
due to an inactive pseudouridine synthase (60). Finally,
Q34 is a G modiﬁcation present in the anticodon loop
of eukaryal and bacterial tRNAs (2,55). It is also
present in a few mt-tRNAs from which tRNA
Asp from
Asterias amurensis, Didelphis virginiana and Rattus
norvegicus. We report here its ﬁrst description in a
human mt-tRNA. This modiﬁcation is likely involved in
codon reading (61).
The enzymatic and chemical structure probing per-
formed on native, post-transcriptionally modiﬁed,
human mt-tRNA
Asp extracted from HeLa cells reveals a
perfect ﬁt between nucleotide reactivities and a cloverleaf
2D folding (Figure 3). These data, diﬀerent from those
found for the corresponding in vitro transcript, illustrate
the role of the post-transcriptional modiﬁcations in the
achievement of functional tRNA
Asp molecules in human
mitochondria. Contribution of post-transcriptional modi-
ﬁcations to tRNA folding and stability is well established
with examples in diﬀerent kingdoms of life and in
mt-tRNAs (62–64).
Classical tertiary interactions in the core but not in
D/T loop interactions, deﬁne the 3D structure
of native mt-tRNA
Asp
Secondary elements of native human mt-tRNA
Asp appear
well deﬁned. The predicted stems (acceptor arm, D-,
anticodon and T-stems) are reactive to double-strand
speciﬁc enzymatic probe and non reactive to chemical
probes. The predicted loops react in an opposite way,
i.e. strong cleavages by the single-strand speciﬁc enzymatic
probe and high reactivity toward chemical probes. Two
main domains of the potential 3D structure have to be
considered in regard to tertiary interactions. D- and
T-loop nucleotides are strongly reactive to probes, not in
support of interactions between these loops. However, the
reactivity of some nucleotides from both loops ﬁts with a
possible role in the tertiary network, according to rules
established for classical tRNAs. Reactivities are compati-
ble for the following interactions: A14–U8, A21–A14 and
A58–C54 (or A58–U55). Reactivities of residues within
the variable domain and of residue 26 are compatible
with the following triples: G10–C25/A45, A13–U12/A46
Nucleic Acids Research, 2009,Vol.37, No. 20 6891and A26–A44. The existence of triple 9/12–23 has been
previously supported experimentally, combining a struc-
tural and functional mutagenic approach (33). Only inter-
action between residues 15 and 48 could not be tested
(reactivity of residue 15 is poisoned by a systematic deg-
radation of the 15–16 phosphodiester bond and U48 is not
sensitive to the probes used herein).
In summary, chemical and enzymatic probing per-
formed herein is concordant with probing performed on
classical tRNAs (65) and can be interpreted by at least
ﬁve out of the six expected tertiary interactions taking
place in the core domain of the tRNA, involving the
D-domain and the variable region. These ﬁndings are
strengthened by compilation of 136 mammalian
mt-tRNA
Asp sequences, which revealed a high conserva-
tion in nucleotides within the core domain of the tRNA
(see Supplementary Data). Moreover, more than 98% of
nucleotide combinations in the full set of 16nt involved in
the six core interactions are compatible with conservation
of Leontis–Westhof interaction types (Table 2).
Accordingly, the six tertiary interactions can exist and
are conserved in mammalian mt-tRNA
Asp.A3 D
graphics model of human mt-tRNA
Asp has been built
accordingly, on the basis of the crystallographic structure
of E. coli tRNA
Asp in complex with the cognate aspartyl-
tRNA synthetase (27). Figure 5 presents the model and
highlights the predicted interactions in the core of the
molecule. It also illustrates the main absence of inter-
actions between the D- and T-loops.
Evolution of mammalian mt-tRNA structures
Mammalian mt-tRNAs are considered as ‘bizarre’ tRNAs
due to skewed nucleotide composition and to important
size and sequence variations in the D- and T-loops. Here
we show that the 3D structure of human mt-tRNA
Asp
is based on a core domain made up of the classical set
of six tertiary interactions. This tRNA presents also a
restricted set of four post-transcriptional modiﬁcations,
all of classical type, from which m
1A9, m
2G10, 27 stabi-
lize the fold. The L-shaped structure remains unusual in
regard to its elbow for which no interactions between the
D- and T-loops could be detected. However, neither the
contribution of residue 60 in the T-loop nor that of
speciﬁc magnesium ions (59) could be evaluated. Rules
determined for human mt-tRNA
Asp can be extended to
136 mammalian mt-tRNAs of the same speciﬁcity.
Detailed structural properties of 19 mammalian
mt-tRNA families of diﬀerent speciﬁcities need to be
explored to verify if the observations established herein
for tRNA
Asp can be generalized, or if on the contrary
some tRNAs present alternative tertiary networks. We
recall that serine speciﬁc tRNAs do possess alternate
networks (8–10). The recent crystal structure of pyrro-
lysine speciﬁc tRNA from Desulﬁtobacterium hafniense
features unprecedented tertiary interactions (66).
These are likely valid for the mt-tRNA
Ser(UCN) which
shares very similar typical secondary structure charac-
teristics (8,9).
The size and sequence degeneracy observed for mam-
malian mt-tRNA D- and T-loops parallels the functional
degeneracy observed for aminoacylation identity sets,
restricted in number as compared to other tRNAs
(14,67,68). Interestingly, local mutation of aspartyl-
tRNA synthetase in response to the loss of the major
identity element G73 is an explicit demonstration of an
adaptation in a complementary partnership (14). More
generally, it is observed that mt-DNA encoded RNA
degeneracy is compensated for by adaptation of partner
macromolecules belonging to the translational machinery.
An extended elongation factor exists speciﬁcally for the
D-stem deprived tRNA
Ser(AGY) (69), a highly protein
rich mitochondrial ribosome compensates for restricted
12S and 16S rRNA sequences coded by the mt genome
(70) and ﬁnally, RNaseP is deprived of an RNA moiety
but enriched in protein subunits (57).
Mammalian mt-tRNA structures remain to be
deﬁned during interaction with e.g. post-transcriptional
Figure 5. 3D structure model for native human mt-tRNA
Asp. The
model has been built on the basis of crystallographic structure of
E. coli tRNA
Asp in complex with its cognate aspartyl-tRNA synthetase
(27). Nucleotides have been exchanged according to the mt-tRNA
sequence, nucleotide 47 in the variable region has been removed, and
D- and T-loops shortened and shaped so that no tertiary interaction
can occur. The model has further been submitted to an energy mini-
mization step. (A) Structure of the tRNA with emphasis of the core
interactions. In the right panel, the CCA-end points toward the reader.
(B) Detailed views on the individual core interactions. The six tertiary
interactions found in classical tRNAs are highlighted in the model, in
agreement with the chemical probing data collected herein and conser-
vation of Leontis–Westhof rules in 136 mammalian mt-tRNA
Asp.
The color code is as follows: A15-U48/magenta; U8–A14–A21/blue;
U22–A13–U46/green; A9–U12–U23/yellow; G10–C25–A45/brown;
A26–A44/red. Figures were prepared with PyMol (31).
6892 Nucleic Acids Research, 2009,Vol.37, No. 20modiﬁcation enzymes, cognate aminoacyl-tRNA synthe-
tases and mito-ribosomal A, P and E-sites. Large plasticity
of tRNA structures is required for each of these part-
nerships when classical tRNAs are considered, as for
example with aminoacyl-tRNA synthetases (e.g. 71),
tRNA-guanine transglycosylase (72), or during interaction
with the ribosome (73,74). Structural knowledge on mam-
malian mt-tRNAs will also allow for better understanding
of the molecular impacts of mutations correlated with
neurodegenerative disorders (43,75).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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